A Multi-Center Phase Ib Study of Oxaliplatin (NSC 266046) in Combination With Fluorouracil and Leucovorin in Pediatric Patients With Advanced Solid Tumors.

Trial Profile

A Multi-Center Phase Ib Study of Oxaliplatin (NSC 266046) in Combination With Fluorouracil and Leucovorin in Pediatric Patients With Advanced Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2015

At a glance

  • Drugs Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Jun 2009 Lead trial centre (National Cancer Institute) added as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Sep 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top